Interdisziplinäres Zentrum für Klinische Forschung (IZKF)

J113: Impact of the secretome of ATF2-deficient colon cancer cells on mesothelial cells during peritoneal metastasis Nov. 1, 2024 - April 30, 2027 J110: Epithelial telomere shortening in the pathogenesis of ulcerative colitis Nov. 1, 2024 - April 30, 2027 Kinase signaling in the immune responses of small-cell lung cancer April 1, 2024 - April 1, 2027 T cell plasticity and functionality under conventional autoimmune disease therapies April 1, 2025 - March 31, 2027 J115: Conjugated steroids in plasma and urine as diagnostic and prognostic biomarkers for adrenocortical carcinoma Aug. 1, 2024 - Jan. 31, 2027 J114: Profiling of transcriptional regulatory circuitries in the development of clear cell renal cell carcinoma Aug. 1, 2024 - Jan. 31, 2027 A100: Soluble CD83-induced pro-resolving macrophages strongly improve and accelerate wound healing processes July 1, 2023 - Dec. 31, 2026 J111: Voxelomic Atlas: Single-Voxel Spatio-Spectral Homology Matching Oct. 1, 2024 - Dec. 31, 2026 J107: Deciphering the PU.1 transcriptional network in osteoblasts and its role in osteoproliferative arthritis Jan. 1, 2024 - Aug. 31, 2026 IZKF-N9 Engineered cells skin dis(601/DE: Dressing up and ready to move: Engineered immune cells for treatment of autoimmune skin diseases July 1, 2024 - June 30, 2026